Tuesday, May 6, 2014
Otitis Media and Xerosis (Dry Skin)- Pipeline Review, H1 2014, Global Industry Analysis, Size, Share, Growth, Trends And Forecast
" Otitis Media and Xerosis (Dry Skin)- Pipeline Review, H1 2014 " is the latest addition to Market Research Reports.biz industry research reports collection. To order report Call +1-518-618-1030 or send an email on email@example.com with Pipeline Review, H1 2014 in subject line.
Global Markets Directs, Otitis Media, Xerosis (Dry Skin) - Pipeline Review, H1 2014, provides an overview of the Otitis Media, Xerosis (Dry Skin) therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Otitis Media, Xerosis (Dry Skin) , complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Otitis Media, Xerosis (Dry Skin) and special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
- The report provides a snapshot of the global therapeutic landscape of Otitis Media, Xerosis (Dry Skin)
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Otitis Media, Xerosis (Dry Skin) and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Otitis Media, Xerosis (Dry Skin) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Otitis Media, Xerosis (Dry Skin) pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Otitis Media, Xerosis (Dry Skin)
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Otitis Media, Xerosis (Dry Skin) pipeline depth and focus of Indication therapeutics
Table of Contents
List of Tables
List of Figures
Global Markets Direct Report Coverage
Otitis Media, Xerosis (Dry Skin) Overview
Pipeline Products for Otitis Media, Xerosis (Dry Skin) - Overview
Pipeline Products for Otitis Media, Xerosis (Dry Skin) - Comparative Analysis 9
Otitis Media, Xerosis (Dry Skin) - Therapeutics under Development by Companies 10
Otitis Media, Xerosis (Dry Skin) - Therapeutics under Investigation by Universities/Institutes 12
Otitis Media, Xerosis (Dry Skin) - Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Otitis Media, Xerosis (Dry Skin) - Products under Development by Companies 16
Otitis Media, Xerosis (Dry Skin) - Products under Investigation by Universities/Institutes 17
Otitis Media, Xerosis (Dry Skin) - Companies Involved in Therapeutics Development 18
Alcon, Inc. 18
GlaxoSmithKline plc 19
Yuhan Corporation 20
Arbor Pharmaceuticals, Inc. 21
MerLion Pharmaceuticals Pte Ltd 22
Otonomy, Inc. 23
Cellceutix Corporation 24
Serum Institute of India Limited 25
BCO Pharma Ltd 26
Otitis Media, Xerosis (Dry Skin) - Therapeutics Assessment 27
Assessment by Monotherapy Products 27
Assessment by Target 28
Assessment by Mechanism of Action 30
Assessment by Route of Administration 32
Market Research Reports.biz is the most comprehensive collection of market research reports. Marketresearchreports.biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207USA - Canada Toll Free: +1-866-997-4948